
Opinion|Videos|April 22, 2024
Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s Disease
Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.
Advertisement
Timecodes:
1:28 Defining ON time in PD
4:50 Dyskinesia experience
8:00 Tremor and dyskinesia
13:30 Dyskinesia and QoL
16:00 Dyskinesia and OFF
19:30 Tailoring treatment
22:00 Amantadine DR/ER
29:00 Amantadine candidates
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players
2
Phase 4 Study Highlights Valbenazine's Positive Impact on Patient-Reported Quality of Life, Daily Functioning in Tardive Dyskinesia
3
EU Approves Modified-Release Carbidopa/Levodopa Capsules for Parkinson Disease Motor Fluctuations
4
Study Shows DMTs Associated With Higher Risk of Gynecologic Complications in Women With MS
5

















